NCT00448422View on ClinicalTrials.gov

Safety and Efficacy of Prulifloxacin vs Placebo in Treatment of Acute Gastroenteritis in Adult Travelers

PHASE3CompletedINTERVENTIONAL

Enrollment

268

Participants

Timeline

Start Date

December 31, 2006

Primary Completion Date

August 31, 2008

Study Completion Date

August 31, 2008

Conditions

Acute Bacterial Gastroenteritis

Interventions

DRUG

prulifloxacin

Tablet

Trial Locations (1)

Unknown

Goa Medical College, Bambolim

All Listed Sponsors

lead

Optimer Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)

INDUSTRY

NCT00448422 - Safety and Efficacy of Prulifloxacin vs Placebo in Treatment of Acute Gastroenteritis in Adult Travelers | Biotech Hunter | Biotech Hunter